Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $4.6 million.

  • Bio-Techne's Change in Taxes rose 21332.67% to $4.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.1 million, marking a year-over-year increase of 6210.78%. This contributed to the annual value of $8.5 million for FY2025, which is 17990.38% up from last year.
  • Per Bio-Techne's latest filing, its Change in Taxes stood at $4.6 million for Q4 2025, which was up 21332.67% from -$27.4 million recorded in Q3 2025.
  • Bio-Techne's Change in Taxes' 5-year high stood at $16.4 million during Q2 2025, with a 5-year trough of -$27.4 million in Q3 2025.
  • Over the past 5 years, Bio-Techne's median Change in Taxes value was $925500.0 (recorded in 2021), while the average stood at -$766950.0.
  • In the last 5 years, Bio-Techne's Change in Taxes crashed by 133297.18% in 2021 and then surged by 25455.23% in 2025.
  • Quarter analysis of 5 years shows Bio-Techne's Change in Taxes stood at $13.7 million in 2021, then fell by 23.49% to $10.5 million in 2022, then increased by 24.34% to $13.1 million in 2023, then tumbled by 130.93% to -$4.0 million in 2024, then soared by 213.33% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q4 2025, -$27.4 million for Q3 2025, and $16.4 million during Q2 2025.